Sprint Corp (NYSE:S) carries the most downside risk of any mega cap in 2017. At almost a $35 billion market cap, this cell carrier is overvalued on almost any metric. Look at the price action in 2016. At the start of the year it traded as low as $2.20 but in December 2016 it hit $9.00. This is a whopping 310% gain in one year. A coming correction will see the stock plummet to $6.50-$7.00. Even there, Sprint will remain overvalued but investors will likely buy it up. I am a seller, looking to profit on Sprint for this collapse. There is also a classic institutional sell program being initiated, seen by the bearish inside bar pattern. It is days away from starting its large decline.







Investors and traders sell the stock chart of Sprint Corp